End-to-End Full-Atom Antibody Design

• URL: http://arxiv.org/abs/2302.00203v4
• Date: Tue, 30 May 2023 02:45:42 GMT
• Title: End-to-End Full-Atom Antibody Design
• Authors: Xiangzhe Kong, Wenbing Huang, Yang Liu
• Abstract summary: There are two major defects in current learning-based methods, making them suboptimal or resource-intensive. We propose dynamic Multi-channel Equivariant grAph Network (dyMEAN), an end-to-end full-atom model for E(3) antibody design. Both 1D sequences and 3D structures are updated via an adaptive multi-channel encoder that is able to process protein residues of variable sizes when considering full atoms. Experiments on CDR-H3 design, complex structure prediction, and affinity optimization demonstrate the superiority of our end-to-end framework and full-atom modeling.
• Score: 28.199522831859998
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Antibody design is an essential yet challenging task in various domains like therapeutics and biology. There are two major defects in current learning-based methods: 1) tackling only a certain subtask of the whole antibody design pipeline, making them suboptimal or resource-intensive. 2) omitting either the framework regions or side chains, thus incapable of capturing the full-atom geometry. To address these pitfalls, we propose dynamic Multi-channel Equivariant grAph Network (dyMEAN), an end-to-end full-atom model for E(3)-equivariant antibody design given the epitope and the incomplete sequence of the antibody. Specifically, we first explore structural initialization as a knowledgeable guess of the antibody structure and then propose shadow paratope to bridge the epitope-antibody connections. Both 1D sequences and 3D structures are updated via an adaptive multi-channel equivariant encoder that is able to process protein residues of variable sizes when considering full atoms. Finally, the updated antibody is docked to the epitope via the alignment of the shadow paratope. Experiments on epitope-binding CDR-H3 design, complex structure prediction, and affinity optimization demonstrate the superiority of our end-to-end framework and full-atom modeling.

Related papers

• Sequence-Augmented SE(3)-Flow Matching For Conditional Protein Backbone Generation [55.93511121486321]
  We introduce FoldFlow-2, a novel sequence-conditioned flow matching model for protein structure generation. We train FoldFlow-2 at scale on a new dataset that is an order of magnitude larger than PDB datasets of prior works. We empirically observe that FoldFlow-2 outperforms previous state-of-the-art protein structure-based generative models.
  arXiv  Detail & Related papers  (2024-05-30T17:53:50Z)
• A Hierarchical Training Paradigm for Antibody Structure-sequence Co-design [54.30457372514873]
  We propose a hierarchical training paradigm (HTP) for the antibody sequence-structure co-design. HTP consists of four levels of training stages, each corresponding to a specific protein modality. Empirical experiments show that HTP sets the new state-of-the-art performance in the co-design problem.
  arXiv  Detail & Related papers  (2023-10-30T02:39:15Z)
• Cross-Gate MLP with Protein Complex Invariant Embedding is A One-Shot Antibody Designer [58.97153056120193]
  The specificity of an antibody is determined by its complementarity-determining regions (CDRs) Previous studies have utilized complex techniques to generate CDRs, but they suffer from inadequate geometric modeling. We propose a textitsimple yet effective model that can co-design 1D sequences and 3D structures of CDRs in a one-shot manner.
  arXiv  Detail & Related papers  (2023-04-21T13:24:26Z)
• xTrimoABFold: De novo Antibody Structure Prediction without MSA [77.47606749555686]
  We develop a novel model named xTrimoABFold to predict antibody structure from antibody sequence. The model was trained end-to-end on the antibody structures in PDB by minimizing the ensemble loss of domain-specific focal loss on CDR and the frame-aligned point loss.
  arXiv  Detail & Related papers  (2022-11-30T09:26:08Z)
• Incorporating Pre-training Paradigm for Antibody Sequence-Structure Co-design [134.65287929316673]
  Deep learning-based computational antibody design has attracted popular attention since it automatically mines the antibody patterns from data that could be complementary to human experiences. The computational methods heavily rely on high-quality antibody structure data, which is quite limited. Fortunately, there exists a large amount of sequence data of antibodies that can help model the CDR and alleviate the reliance on structure data.
  arXiv  Detail & Related papers  (2022-10-26T15:31:36Z)
• Reprogramming Pretrained Language Models for Antibody Sequence Infilling [72.13295049594585]
  Computational design of antibodies involves generating novel and diverse sequences, while maintaining structural consistency. Recent deep learning models have shown impressive results, however the limited number of known antibody sequence/structure pairs frequently leads to degraded performance. In our work we address this challenge by leveraging Model Reprogramming (MR), which repurposes pretrained models on a source language to adapt to the tasks that are in a different language and have scarce data.
  arXiv  Detail & Related papers  (2022-10-05T20:44:55Z)
• Conditional Antibody Design as 3D Equivariant Graph Translation [28.199522831859998]
  We propose Multi-channel Equivariant Attention Network (MEAN) to co-design 1D sequences and 3D structures of CDRs. Our method significantly surpasses state-of-the-art models in sequence and structure modeling, antigen-binding CDR design, and binding affinity optimization.
  arXiv  Detail & Related papers  (2022-08-12T01:00:59Z)
• Iterative Refinement Graph Neural Network for Antibody Sequence-Structure Co-design [35.215029426177004]
  We propose a generative model to automatically design antibodies with enhanced binding specificity or neutralization capabilities. Our method achieves superior log-likelihood on the test set and outperforms previous baselines in designing antibodies capable of neutralizing the SARS-CoV-2 virus.
  arXiv  Detail & Related papers  (2021-10-09T18:23:32Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.